In animal models of AD and in mice injected with Aβ oligomers, anakinra was reported to reduce brain inflammation, p-tau, cognitive deficits, synaptic loss and ameliorate cognitive impairment (Kitazawa et al., 2011; Batista et al., 2021). This evidence concerns the gene MAPT and Alzheimer disease.